Director Study Leader, Cell Therapy
Company: AstraZeneca
Location: Montgomery Village
Posted on: July 1, 2025
|
|
Job Description:
The Director Study Leader, Cell Therapy is responsible for
delivering one or several smaller Cell Therapy development programs
or leading multiple Cell Therapy studies, including complex and
novel studies such as platform and basket trials. The specific
accountabilities will vary based on the nature of the clinical
studies or program. Reporting to the Sr. Director Group Leader,
Cell Therapy, you may also provide expert input to non-drug
programs and process improvement projects. Accountabilities Provide
clinical operational input into project or study level documents
and may lead the delivery of study documents. With oversight from
the Clinical Program Director, Cell Therapy, lead and deliver
outstanding and operational options for review at Investment
Decision Governance interactions. Lead the delivery of clinical
study(s) or program(s) from concept to final CSR and through to
study closure and archiving, ensuring adherence to budget, time,
project standards, quality, and scientific standards. Optimize the
performance of study delivery teams ensuring GCP compliance,
including providing accurate performance feedback for study team
members to the appropriate AZ manager or CRO representative.
Maintain oversight throughout the life of the study or program,
ensuring overall deliverables are met. May have 5 direct/indirect
reports. Implement agreed study level processes and technology for
assigned Cell Therapy clinical studies. Lead risk
management/mitigation plans to ensure delivery to quality, budget,
and time, raising issues to partners as necessary. Provide input to
forecasting and management of study delivery costs, resources, and
timelines. Ensure quality of study/program planning information
into relevant planning systems (e.g., PLANIT) in collaboration with
counterparts in relevant therapeutic areas. Guide the Study Team in
developing outsourcing specifications and vendor selection. Provide
procurement with clear specifications for study or program-specific
outsourcing. Review and operationally approve study or
program-specific contracts or work orders. Lead all aspects of CROs
and other clinically outsourced third-party vendors. Communicate
study level reports and status updates for assigned Cell Therapy
studies, including progress issues Lead risk management and quality
efforts to ensure study compliance and inspection readiness for
apheresis and cell therapy infusion activities. May lead study
delivery-related activities associated with regulatory
inspections/audits in liaison with Clinical QA for apheresis and
cell therapy infusion activities. Contribute to operational
interactions with external entities including regulatory agencies,
preferred partners/suppliers, and external collaborators.
Responsible for the submission of essential documents to the Trial
Master File, maintenance, and final closeout. Essential
Skills/Experience BS degree in related field or biological science
10 years drug development experience 5 years leading
studies/programs in clinical development 3 years of direct Cell
Therapy experience Clinical drug development process knowledge
Leading delivery through internal and external organizations
ICH-GCP principles Selection and oversight of external providers
and development/providing clear requirements of contracts Early
phase clinical delivery and in autologous or allogeneic therapies
in oncology The annual base salary for this position ranges from
$162,566.00 to $243,849.66. However, base pay offered may vary
depending on multiple individualized factors, including market
location, job-related experience. If hired, employee will be in an
"at-will position" and we reserve the right to modify base salary
(and any other discretionary payment or compensation program) at
any time, including for reasons related to individual performance,
Company or individual department/team performance, and market
factors. When we put unexpected teams in the same room, we unleash
bold thinking with the power to inspire life-changing medicines.
In-person working gives us the platform we need to connect, work at
pace and challenge perceptions. Thats why we work, on average, a
minimum of three days per week from the office. But that doesnt
mean were not flexible. We balance the expectation of being in the
office while respecting individual flexibility. Join us in our
unique and ambitious world. At AstraZeneca, we follow the science
and pioneer new frontiers. Join our dedicated Oncology team with an
ambition to eliminate cancer as a cause of death. Our vision unites
and inspires us as we push forward with cutting-edge science and
technology to achieve breakthroughs. With multiple indications and
high-quality molecules at all stages of our innovative pipeline, we
aim to deliver six new molecular entities by 2025. Be part of a
place built on courage, curiosity, and collaboration where bold
decisions are driven by patient outcomes. Empowered at every level,
you will have the opportunity to build a rewarding career while
improving the lives of millions with cancer. Ready to make a
difference? Apply now! AstraZeneca embraces diversity and equality
of opportunity. We are committed to building an inclusive and
diverse team representing all backgrounds, with as wide a range of
perspectives as possible, and harnessing industry-leading skills.
We believe that the more inclusive we are, the better our work will
be. We welcome and consider applications to join our team from all
qualified candidates, regardless of their characteristics. We
comply with all applicable laws and regulations on
non-discrimination in employment (and recruitment), as well as work
authorization and employment eligibility verification
requirements.
Keywords: AstraZeneca, Bowie , Director Study Leader, Cell Therapy, Science, Research & Development , Montgomery Village, Maryland